Item 7.01. Regulation FD Disclosure.

On March 12, 2020, Menlo Therapeutics Inc. (the "Company") issued a press release entitled "Menlo Reports Financial Results for Subsidiary Foamix Pharmaceuticals for Year Ended December 31, 2019." A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

The following exhibits are filed herewith.

Exhibit No. Description

99.1 Press release, dated March 12, 2020

© Edgar Online, source Glimpses